Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

Penny stock under Rs 5; Board likely to announce bonus shares, stock split and dividend!

Kiran Shroff

The shares of the company saw a spurt in volume by more than 2.20 times on BSE.

Earum Pharmaceuticals Ltd inform that a meeting of the Board of Directors of the Company will be held on Friday, July 14, 2023 to discuss and consider inter alia:

  1. The proposal for Buyback of Equity Shares of the Company.
  2. The proposal to recommend the declaration of the Final dividend for the F.Y. 2022-23.
  3. The proposal to Issue of bonus Equity Shares to the existing equity Shareholders of the Company.
  4. The proposal for the sub-division of equity shares of the Company.
  5. To finalize the date, day, time and venue of the Annual General Meeting of shareholders for the F.Y. 2022-23.

 

Want more insightful stories along with recommendations?
Get a 3-month subscription to experience the power of our flagship DSIJ Magazine (online edition) for just Rs 800/-  Click here to subscribe now

Earum Pharmaceuticals Limited produces and distributes pharmaceutical products. The Company offers tablets, capsules, ointments, creams, gels, powders, and syrup. Earum Pharmaceuticals markets its products globally.

Earum Pharmaceuticals has a market cap of Rs 44.97 crore. The company reported positive numbers in its both Quarterly Results and annual results.

On Friday, shares of Earum Pharmaceuticals plunged 8.54 per cent to Rs 1.82 per share from its previous closing of Rs 1.99. The shares of the company saw a spurt in volume by more than 2.20 times on BSE. Investors should keep an eye on this micro-cap stock.

Previous Article 2200 per cent returns: This SME stock got final approval to mitigate to capital market segment of NSE!
Next Article 600 per cent returns: This civil construction company bags order worth Rs 1,008 crore!
Rate this article:
3.7

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR